What are the Hemophagocytic Lymphohistiocytosis (HLH) criteria after Stem Cell Transplant (SCT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hemophagocytic Lymphohistiocytosis (HLH) diagnosis after Stem Cell Transplant (SCT) is defined by elevated ferritin of >10,000 ng/mL, along with at least two organ toxicities, including the presence of hemophagocytosis in bone marrow or organs, or at least grade 3 transaminitis, renal insufficiency, or pulmonary edema, as proposed in the most recent guidelines 1.

Key Diagnostic Criteria

The diagnostic criteria for HLH after SCT include:

  • Elevated ferritin of >10,000 ng/mL
  • At least two organ toxicities, such as:
    • Hemophagocytosis in bone marrow or organs
    • Grade 3 transaminitis
    • Renal insufficiency
    • Pulmonary edema

Clinical Presentation

Presenting symptoms related to CAR T–induced HLH may include:

  • Fever
  • Enlarged spleen
  • Enlarged liver
  • Swollen lymph nodes
  • Skin rash
  • Jaundice
  • Lung problems such as coughing and trouble breathing
  • Digestive problems such as stomach ache, vomiting, and diarrhea
  • Nervous system problems such as headaches, trouble walking, vision disturbances, and weakness

Treatment

Treatment for HLH after SCT typically involves:

  • Corticosteroids and IL-6 antagonist therapy for grade 3 or greater organ toxicity
  • Etoposide may be used, although data in CAR T-cell therapy recipients are lacking 1
  • Anakinra has been used for refractory HLH in CAR T-cell therapy recipients, although clinical efficacy is unclear 1 It is essential to note that the diagnosis and treatment of HLH after SCT can be challenging due to overlapping symptoms with other conditions, and prompt recognition and treatment are critical to improve outcomes 1.

From the Research

Hemophagocytic Lymphohistiocytosis (HLH) Criteria after Stem Cell Transplant (SCT)

The diagnosis of HLH after SCT can be challenging due to overlapping symptoms with common post-transplant complications. The following criteria have been mentioned in the studies:

  • Hyperferritinemia 2, 3, 4, 5, 6
  • Increased macrophage count in bone marrow 6
  • Pancytopenia 2
  • Hypertriglyceridemia 2
  • Extensive hemophagocytosis involving the bone marrow and spleen 2
  • Splenomegaly 6
  • Elevated serum ferritin levels, with varying thresholds (500-10,000 μg/mL) 5
  • Increased percentage of macrophages and hemophagocytes in bone marrow aspirates 6

Diagnostic Criteria

Different studies have used various diagnostic criteria, including:

  • HLH-2004 guidelines 2, 4, 5
  • HLH-94 guidelines 4
  • H score 5
  • PT-HLH criteria (hyperferritinemia and increased macrophage count in bone marrow) 6

Challenges in Diagnosis

The diagnosis of HLH after SCT is complicated by the similarity in symptoms with other post-transplant complications, such as:

  • Engraftment syndrome 2, 4
  • Graft-vs-host disease 2, 4, 5
  • Infections 2, 4
  • Cytokine release syndrome (CRS) 5
  • Systemic inflammatory response syndrome (SIRS) 4
  • Thrombotic microangiopathy 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.